Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance

Dalton Trans. 2016 Nov 29;45(47):18876-18891. doi: 10.1039/c6dt01388k.

Abstract

We report on platinum(ii) complexes with different cinnamic acid derivatives as ligands with cytotoxic activity against Cisplatin resistant ovarian cancer cell line subcultures of SKOV3 and A2780. A typical mechanism of action for platinum(ii) complexes as Cisplatin itself is binding to the DNA and inducing double-strand breaks. We examined the biological behavior of these potential drugs with 9-methylguanine using NMR spectroscopic methods and their DNA damage potential including γH2AX-foci analyses. X-ray diffraction methods have been used to elucidate the molecular structures of the platinum(ii) complexes. Interactions with the model protein lysozyme have been evaluated by different techniques including UV-Vis absorption spectroscopy, fluorescence and X-ray crystallography.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cinnamates / chemical synthesis
  • Cinnamates / chemistry
  • Cisplatin / pharmacology*
  • DNA Damage*
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Ligands
  • Molecular Structure
  • Organoplatinum Compounds / chemical synthesis
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacology*

Substances

  • Antineoplastic Agents
  • Cinnamates
  • Ligands
  • Organoplatinum Compounds
  • cinnamic acid
  • Cisplatin